» Articles » PMID: 18953337

De Novo DNA Methylation Promoted by G9a Prevents Reprogramming of Embryonically Silenced Genes

Overview
Date 2008 Oct 28
PMID 18953337
Citations 237
Authors
Affiliations
Soon will be listed here.
Abstract

The pluripotency-determining gene Oct3/4 (also called Pou5f1) undergoes postimplantation silencing in a process mediated by the histone methyltransferase G9a. Microarray analysis now shows that this enzyme may operate as a master regulator that inactivates numerous early-embryonic genes by bringing about heterochromatinization of methylated histone H3K9 and de novo DNA methylation. Genetic studies in differentiating embryonic stem cells demonstrate that a point mutation in the G9a SET domain prevents heterochromatinization but still allows de novo methylation, whereas biochemical and functional studies indicate that G9a itself is capable of bringing about de novo methylation through its ankyrin domain, by recruiting Dnmt3a and Dnmt3b independently of its histone methyltransferase activity. These modifications seem to be programmed for carrying out two separate biological functions: histone methylation blocks target-gene reactivation in the absence of transcriptional repressors, whereas DNA methylation prevents reprogramming to the undifferentiated state.

Citing Articles

Systems Biology of Recombinant 2G12 and 353/11 mAb Production in CHO-K1 Cell Lines at Phosphoproteome Level.

Sulaj E, Sandell F, Schwaigerlehner L, Marzban G, Dohm J, Kunert R Proteomes. 2025; 13(1).

PMID: 39982319 PMC: 11843875. DOI: 10.3390/proteomes13010009.


Post-transcriptional regulation of the transcriptional apparatus in neuronal development.

Nazim M Front Mol Neurosci. 2025; 17():1483901.

PMID: 39764514 PMC: 11701043. DOI: 10.3389/fnmol.2024.1483901.


Maturation and persistence of CAR T cells derived from human pluripotent stem cells via chemical inhibition of G9a/GLP.

Jing R, Falchetti M, Han T, Najia M, Hensch L, Meader E Cell Stem Cell. 2024; 32(1):71-85.e5.

PMID: 39504968 PMC: 11698653. DOI: 10.1016/j.stem.2024.10.004.


TASOR expression in naive embryonic stem cells safeguards their developmental potential.

Pinzon-Arteaga C, OHara R, Mazzagatti A, Ballard E, Hu Y, Pan A Cell Rep. 2024; 43(11):114887.

PMID: 39453814 PMC: 11646706. DOI: 10.1016/j.celrep.2024.114887.


Transdifferentiation occurs without resetting development-specific DNA methylation, a key determinant of full-function cell identity.

Radwan A, Eccleston J, Sabag O, Marcus H, Sussman J, Ouro A Proc Natl Acad Sci U S A. 2024; 121(39):e2411352121.

PMID: 39292740 PMC: 11441492. DOI: 10.1073/pnas.2411352121.


References
1.
Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K . In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature. 2007; 448(7151):318-24. DOI: 10.1038/nature05944. View

2.
Smallwood A, Esteve P, Pradhan S, Carey M . Functional cooperation between HP1 and DNMT1 mediates gene silencing. Genes Dev. 2007; 21(10):1169-78. PMC: 1865489. DOI: 10.1101/gad.1536807. View

3.
Collins R, Northrop J, Horton J, Lee D, Zhang X, Stallcup M . The ankyrin repeats of G9a and GLP histone methyltransferases are mono- and dimethyllysine binding modules. Nat Struct Mol Biol. 2008; 15(3):245-50. PMC: 2586904. DOI: 10.1038/nsmb.1384. View

4.
Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, Arnold K . Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell. 2008; 1(1):55-70. DOI: 10.1016/j.stem.2007.05.014. View

5.
Shi Y, Do J, Desponts C, Hahm H, Scholer H, Ding S . A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell. 2008; 2(6):525-8. DOI: 10.1016/j.stem.2008.05.011. View